While the study only involved narcolepsy type 1, previous work has shown that orexin signaling may be deficient in other ...

To know whether you have narcolepsy, it's important to recognize a few common symptoms, such as excessive daytime sleepiness.

Alkermes has reached an agreement to buy Avadel Pharma in a deal valued at up to $2.1 billion, claiming rights to an ...

When entrepreneur and author Michelle Weger first started falling asleep in her university classrooms at 17, the teenager who ...

Analysts called the proposed purchase of Avadel Pharmaceuticals a “clear” strategic fit for Alkermes, handing it an already marketed product for excessive daytime sleepiness.

Cataplexy is a rare symptom linked to narcolepsy. The right diagnosis and treatment can help you manage these sudden episodes ...

Recent research has shed light on the complex neural processes that transition our brains from sleep to wakefulness, ...

Brain clearance involves three types of pulsation: cardiovascular pulsations generated by the heartbeat in the arteries, respiratory pulsations in the veins and cerebrospinal fluid spaces, and slow ...

A hormone produced by the brain, orexin, may play a central role in the functioning of the brain’s glymphatic system, which clears waste, according to a new study from the University of Oulu.

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Alkermes and Takeda ...

Takeda and Alkermes both took data from their orexin receptor 2 (OX2R)-selective agonists to Singapore this morning as the race to get a new class of narcolepsy drugs approved heats up. Takeda ...

Alkermes said on Wednesday it will acquire Avadel Pharmaceuticals in a deal valued at up to $2.1 billion, gaining an approved ...